Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons
Abstract
Erythropoietin receptor (EpoR) binding mediates neuroprotection by endogenous Epo or by exogenous recombinant human (rh)Epo. The level of EpoR gene expression may determine tissue responsiveness to Epo. Thus, harnessing the neuroprotective power of Epo requires an understanding of the Epo–EpoR system and its regulation. We tested the hypothesis that neuronal expression of EpoR is required to achieve optimal neuroprotection by Epo. The ventral limbic region (VLR) in the rat brain was used because we determined that its neurons express minimal EpoR under basal conditions, and they are highly sensitive to excitotoxic damage, such as occurs with pilocarpine-induced status epilepticus (Pilo-SE). We report that (i) EpoR expression is significantly elevated in nearly all VLR neurons when rats are subjected to 3 moderate hypoxic exposures, with each separated by a 4-day interval; (ii) synergistic induction of EpoR expression is achieved in the dorsal hippocampus and neocortex by the combination of hypoxia and exposure to an enriched environment, with minimal increased expression by either treatment alone; and (iii) rhEpo administered after Pilo-SE cannot rescue neurons in the VLR, unless neuronal induction of EpoR is elicited by hypoxia before Pilo-SE. This study thus demonstrates using environmental manipulations in normal rodents, the strict requirement for induction of EpoR expression in brain neurons to achieve optimal neuroprotection. Our results indicate that regulation of EpoR gene expression may facilitate the neuroprotective potential of rhEpo.
Acknowledgments.
We thank D. Ressnikoff and Y. Tourneur from the Centre Commun de Quantimétrie (University of Lyon 1) for their assistance in the use of the confocal microscope. This work was supported by grants from the Centre National de la Recherche Scientifique and the University of Lyon 1. P.E.S. is a fellow from the Délégation Générale pour l'Armement, Ministère Français de la Défense.
Supporting Information
Supporting Information (PDF)
Supporting Information
- Download
- 652.92 KB
References
1
M Brines, A Cerami, Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6, 484–494 (2005).
2
K Maiese, ZZ Chong, F Li, YC Shang, Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies. Prog Neurobiol 85, 194–213 (2008).
3
CT Noguchi, P Asavaritikrai, R Teng, Y Jia, Role of erythropoietin in the brain. Crit Rev Oncol Hematol 64, 159–171 (2007).
4
H Ehrenreich, et al., Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8, 495–505 (2002).
5
H Ehrenreich, et al., Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 12, 206–220 (2007).
6
H Ehrenreich, et al., Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130, 2577–2588 (2007).
7
ZY Chen, R Warin, CT Noguchi, Erythropoietin and normal brain development: Receptor expression determines multi-tissue response. Neurodegener Dis 3, 68–75 (2006).
8
J Nadam, et al., Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol Dis 25, 412–426 (2007).
9
L Covolan, LE Mello, Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus. Epilepsy Res 39, 133–152 (2000).
10
H Ehrenreich, et al., A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci USA 102, 862–867 (2005).
11
R Liu, A Suzuki, Z Guo, Y Mizuno, T Urabe, Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro. J Neurochem 96, 1101–1110 (2006).
12
X Yu, et al., Erythropoietin receptor signalling is required for normal brain development. Development 129, 505–516 (2002).
13
M Bernaudin, et al., Neurons and astrocytes express EPO mRNA: Oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30, 271–278 (2000).
14
J Soliz, M Gassmann, V Joseph, Soluble erythropoietin receptor is present in the mouse brain and is required for the ventilatory acclimatization to hypoxia. J Physiol 583, 329–336 (2007).
15
C Liu, K Shen, Z Liu, CT Noguchi, Regulated human erythropoietin receptor expression in mouse brain. J Biol Chem 272, 32395–32400 (1997).
16
I Shams, E Nevo, A Avivi, Erythropoietin receptor spliced forms differentially expressed in blind subterranean mole rats. FASEB J 19, 1749–1751 (2005).
17
R Yamaji, et al., The intron 5-inserted form of rat erythropoietin receptor is expressed as a membrane-bound form. Biochim Biophys Acta 1403, 169–178 (1998).
18
K Chin, et al., Production and processing of erythropoietin receptor transcripts in brain. Mol Brain Res 81, 29–42 (2000).
19
FR Sharp, M Bernaudin, HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5, 437–448 (2004).
20
MI Assaraf, et al., Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol 66, 389–398 (2007).
21
H Ehrenreich, et al., Erythropoietin: A candidate compound for neuroprotection in schizophrenia. Mol Psychiatr 9, 42–54 (2004).
22
T Eid, et al., Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis. J Neuropathol Exp Neurol 63, 73–83 (2004).
23
AL Siren, et al., Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 101, 271–276 (2001).
24
M Bernaudin, et al., A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19, 643–651 (1999).
25
G Grasso, et al., Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery 56, 821–827 (2005).
26
S Malhotra, SI Savitz, L Ocava, DM Rosenbaum, Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 83, 19–27 (2006).
27
J Nithianantharajah, AJ Hannan, Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 7, 697–709 (2006).
28
H van Praag, G Kempermann, FH Gage, Neural consequences of environmental enrichment. Nat Rev Neurosci 1, 191–198 (2000).
29
C Rampon, et al., Effects of environmental enrichment on gene expression in the brain. Proc Natl Acad Sci USA 97, 12880–12884 (2000).
30
M Digicaylioglu, G Garden, S Timberlake, L Fletcher, SA Lipton, Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc Natl Acad Sci USA 101, 9855–9860 (2004).
31
ZY Chen, P Asavaritikrai, JT Prchal, CT Noguchi, Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem 282, 25875–25883 (2007).
32
NA Shein, M Horowitz, AG Alexandrovich, J Tsenter, E Shohami, Heat acclimation increases hypoxia-inducible factor 1alpha and erythropoietin receptor expression: Implication for neuroprotection after closed head injury in mice. J Cereb Blood Flow Metab 25, 1456–1465 (2005).
33
JM Gidday, Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7, 437–448 (2006).
34
K Ruscher, et al., Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: Evidence from an in vitro model. J Neurosci 22, 10291–10301 (2002).
35
R Auvergne, et al., Delayed kindling epileptogenesis and increased neurogenesis in adult rats housed in an enriched environment. Brain Res 954, 277–285 (2002).
36
D Young, PA Lawlor, P Leone, M Dragunow, MJ During, Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 5, 448–453 (1999).
37
SA Lipton, Pathologically activated therapeutics for neuroprotection. Nat Rev Neurosci 8, 803–808 (2007).
38
O Ravid, et al., An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation. Proc Natl Acad Sci USA 104, 14360–14365 (2007).
39
A Morales, et al., Unexpected expression of orexin-B in basal conditions and increased levels in the adult rat hippocampus during pilocarpine-induced epileptogenesis. Brain Res 1109, 164–175 (2006).
40
PE Sanchez, et al., Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. J Comp Neurol 514, 403–414 (2009).
41
LC Schmued, KJ Hopkins, Fluoro-Jade B: A high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874, 123–130 (2000).
42
G Paxinos, C Watson The Rat Brain in Stereotaxic Coordinates (Academic, 4th Ed, New York), pp. 256 (1998).
Information & Authors
Information
Published in
Classifications
Copyright
© 2009.
Submission history
Received: August 1, 2008
Published online: June 16, 2009
Published in issue: June 16, 2009
Keywords
Acknowledgments
We thank D. Ressnikoff and Y. Tourneur from the Centre Commun de Quantimétrie (University of Lyon 1) for their assistance in the use of the confocal microscope. This work was supported by grants from the Centre National de la Recherche Scientifique and the University of Lyon 1. P.E.S. is a fellow from the Délégation Générale pour l'Armement, Ministère Français de la Défense.
Notes
This article contains supporting information online at www.pnas.org/cgi/content/full/0901840106/DCSupplemental.
Authors
Competing Interests
The authors declare no conflict of interest.
Metrics & Citations
Metrics
Citation statements
Altmetrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
Cited by
Loading...
View Options
View options
PDF format
Download this article as a PDF file
DOWNLOAD PDFLogin options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginRecommend to a librarian
Recommend PNAS to a LibrarianPurchase options
Purchase this article to access the full text.